National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting, 53432-53433 [2024-14027]

Download as PDF 53432 Federal Register / Vol. 89, No. 123 / Wednesday, June 26, 2024 / Notices Sherrette A. Funn, Paperwork Reduction Act Reports Clearance Officer, Office of the Secretary. [FR Doc. 2024–13944 Filed 6–25–24; 8:45 am] Anticipated Number of Awards BILLING CODE 4150–36–P The IHS anticipates issuing approximately one award under this program announcement. DEPARTMENT OF HEALTH AND HUMAN SERVICES Indian Health Service Funding Opportunity for Increasing the Representation of American Indians and Alaska Natives in Sanitation and Engineering Management Announcement Type: New. Funding Announcement Number: HHS–2024–IHS–SEM–0001. Assistance Listing (Catalog of Federal Domestic Assistance or CFDA) Number: 93.445. Key Dates Application Deadline Date: July 10, 2024. Earliest Anticipated Start Date: August 1, 2024. I. Funding Opportunity Description Statutory Authority The Indian Health Service (IHS) is accepting applications for a Single (Sole) Source Cooperative Agreement from the American Indian Science and Engineering Society (AISES) for Increasing the Representation of American Indian and Alaska Native (AI/ AN) people in science, technology, engineering, and mathematic (STEM) fields. This program is authorized under the Snyder Act, 25 U.S.C. 13; and the Transfer Act, 42 U.S.C. 2001(a). The Assistance Listings section of SAM.gov (https://sam.gov/content/home) describes this program under 93.445. ddrumheller on DSK120RN23PROD with NOTICES1 Purpose The purpose of this program is to increase representation of AI/AN people in STEM fields by increasing visibility and awareness of lesser-known STEM applied public health occupational and student opportunities as well as the benefits of these opportunities. The full Notice of Funding Opportunity and all application materials can be found on Grants.gov at https://grants.gov/search-results-detail/ 354775. II. Award Information Funding Instrument—Cooperative Agreement Estimated Funds Available The total funding identified for fiscal year (FY) 2024 is approximately VerDate Sep<11>2014 18:15 Jun 25, 2024 Jkt 262001 $30,000. We estimate $215,000 in FY 2025, $175,000 in FY 2026, $175,000 in FY 2027 and $150,000 for FY 2028. protect and advance the physical and mental health of the American people. Roselyn Tso, Director, Indian Health Service. [FR Doc. 2024–13949 Filed 6–25–24; 8:45 am] BILLING CODE 4166–14–P Period of Performance DEPARTMENT OF HEALTH AND HUMAN SERVICES The period of performance is for 5 years. National Institutes of Health III. Eligibility Information Office of the Director; Notice of Charter Renewal 1. Eligibility This award is offered as a single source cooperative agreement to the AISES. Note: Please refer to Section IV.2 (Application and Submission Information/ Subsection 2, Content and Form of Application Submission) for additional proof of applicant status documents required, such as proof of nonprofit status, etc. IV. Agency Contacts 1. Questions on the program matters may be directed to: Ms. Melissa de Vera, Assistant Director, Indian Health Service Headquarters, Division of Sanitation Facilities Construction, 5600 Fishers Lane, Mail Stop: 10N13, Rockville, MD 20897, Phone: (240) 462– 4126, Email: Melissa.Devera@ihs.gov. 2. Questions on awards management and fiscal matters may be directed to: Indian Health Service, Division of Grants Management, 5600 Fishers Lane, Mail Stop: 09E70, Rockville, MD 20857, Email: DGM@ihs.gov. 3. For technical assistance with Grants.gov, please contact the Grants.gov help desk at (800) 518–4726, or by email at support@grants.gov. 4. For technical assistance with GrantSolutions, please contact the GrantSolutions help desk at (866) 577– 0771, or by email at help@ grantsolutions.gov. The Public Health Service strongly encourages all grant, cooperative agreement, and contract recipients to provide a smoke-free workplace and promote the non-use of all tobacco products. In addition, Public Law 103– 227, the Pro-Children Act of 1994, prohibits smoking in certain facilities (or in some cases, any portion of the facility) in which regular or routine education, library, day care, health care, or early childhood development services are provided to children. This is consistent with the HHS mission to Frm 00051 Fmt 4703 Dated: June 21, 2024. Patricia B. Hansberger, Deputy Director, Office of Federal Advisory Committee Policy. [FR Doc. 2024–14028 Filed 6–25–24; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health V. Other Information PO 00000 In accordance with title 41 of the U.S. Code of Federal Regulations, section 102–3.65(a), notice is hereby given that the Charter for the National Institutes of Health Clinical Center Research Hospital Board was renewed for an additional two-year period on June 15, 2024. It is determined that the National Institutes of Health Clinical Center Research Hospital Board is in the public interest in connection with the performance of duties imposed on the National Institutes of Health by law, and that these duties can best be performed through the advice and counsel of this group. Inquiries may be directed to Claire Harris, Director, Office of Federal Advisory Committee Policy, Office of the Director, National Institutes of Health, 6701 Democracy Boulevard, Suite 1000, Bethesda, Maryland 20892 (Mail code 4875), Telephone (301) 496– 2123, or harriscl@mail.nih.gov. Sfmt 4703 National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial E:\FR\FM\26JNN1.SGM 26JNN1 Federal Register / Vol. 89, No. 123 / Wednesday, June 26, 2024 / Notices property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. DEPARTMENT OF HOMELAND SECURITY Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; Time-Sensitive Obesity Review. Date: July 23, 2024. Time: 10:00 a.m. to 11:30 a.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, NIDDK, Democracy II, Suite 7000A, 6707 Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Michele L. Barnard, Ph.D., Scientific Review Officer, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Health, 6707 Democracy Boulevard, Rm. 7353, Bethesda, MD 20892–2542, (301) 594–8898, barnardm@ extra.niddk.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS) Cooperative Research and Development Agreement: Payload Incorporated With Computer Vision and Machine Learning Dated: June 21, 2024. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–14027 Filed 6–25–24; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health ddrumheller on DSK120RN23PROD with NOTICES1 National Cancer Institute; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the National Cancer Institute Council of Research Advocates, June 26, 2024, 12:00 p.m. to June 26, 2024, 3:00 p.m., National Institutes of Health, Building 31, 9000 Rockville Pike, Bethesda, MD, 20892 (Virtual Meeting), which was published in the Federal Register on June 11, 2024, FR Doc. 2024–12736, 89 FR 49181. This notice is being amended to change the meeting start and end times. The meeting will now be held from 12:15 p.m. to 3:15 p.m. instead of from 12:00 p.m. to 3:00 p.m. The meeting is open to the public. Dated: June 21, 2024. David W. Freeman, Supervisory Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–14026 Filed 6–25–24; 8:45 am] BILLING CODE 4140–01–P VerDate Sep<11>2014 18:15 Jun 25, 2024 Jkt 262001 Coast Guard [Docket Number USCG–2024–0383] Coast Guard, DHS. Notice of intent; request for comments. AGENCY: ACTION: The Coast Guard is announcing its intent to enter into a Cooperative Research and Development Agreement (CRADA) with AeroVironment, Inc. to evaluate payload(s) that can accelerate autonomy to fielded assets and uncrewed platforms, and automated overhead imagery analysis tool software. The Coast Guard is currently considering partnering with AeroVironment, Inc. to investigate their payload that seamlessly integrates with current AeroVironment UAS in use by the Coast Guard and solicits public comment on the possible participation of other parties in the proposed CRADA, and the nature of that participation. While the Coast Guard is currently considering partnering with AeroVironment, Inc., we are soliciting public comment on the possible nature of and participation of other parties in the proposed CRADA. In addition, the Coast Guard also invites other potential Federal participants, who have the interest and capability to bring similar contributions to this type of research, to consider submitting proposals for consideration in similar CRADAs. DATES: Your comments and related material must reach the Coast Guard on or before July 26, 2024. ADDRESSES: You may submit comments identified by docket number USCG– 2024–0383 using the Federal portal at https://www.regulations.gov. See the ‘‘Public Participation and Request for Comments’’ portion of the SUPPLEMENTARY INFORMATION section for further instructions on submitting comments. SUMMARY: If you have questions about this notice of intent, call or email Ms. Shelly Wyman, U.S. Coast Guard Research and Development Center; telephone 860– 271–2600, email RDC-info@uscg.mil. SUPPLEMENTARY INFORMATION: FOR FURTHER INFORMATION CONTACT: I. Table of Abbreviations CRADA Cooperative Research and Development Agreement DHS Department of Homeland Security PO 00000 Frm 00052 Fmt 4703 Sfmt 4703 53433 MDA Maritime Domain Awareness U.S.C. United States Code II. Background and Purpose The Coast Guard Research and Development Center (R&D Center) is the Coast Guard’s sole facility performing research, development, and test and evaluation in support of the service’s major missions. The R&D Center supports the evaluation of feasibility and affordability of mission execution solutions. When appropriate, the R&D Center collaborates with relevant professionals in the public and private sectors on technology evaluation and/or technology advancement. Persistent surveillance can be defined as a collection strategy that emphasizes the ability of some collection systems to linger on demand in an area to detect, locate, characterize, identify, track, target, in near or real-time. Persistent surveillance requires an operationally focused surveillance approach that uses a full range of strategic, operational, and tactical collection methods to dwell on and revisit a target. In the Coast Guard Strategic Plan, rapidly advancing technologies, including those in uncrewed platforms, data analytics, artificial intelligence, and machine learning need to be harnessed for possible use in mission execution. The ability to detect, locate, characterize, identify, and track people or objects in the water in near or realtime and to apply that technology to Coast Guard sensors and systems has the potential to improve mission support to meet the needs of the Coast Guard today and in the foreseeable future. In the Coast Guard Strategic Plan, two major goals are to direct efforts to encourage developing innovative ways to increase delivery and efficiency of mission support functions; and to strengthen or expedite acquisition process to adopt new technologies that will enhance frontline operations. The ability to enhance our existing systems to incorporate innovative track processing capabilities that may incorporate computer vision and/or machine learning technology for search and rescue missions may greatly increase mission performance on select platforms and improve Maritime Domain Awareness (MDA). III. Public Participation and Request for Comments We request public comments on this notice. Although we do not plan to respond to comments in the Federal Register, we will respond directly to commenters and may modify our proposal in light of comments. E:\FR\FM\26JNN1.SGM 26JNN1

Agencies

[Federal Register Volume 89, Number 123 (Wednesday, June 26, 2024)]
[Notices]
[Pages 53432-53433]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-14027]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Diabetes and Digestive and Kidney Diseases; 
Notice of Closed Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial

[[Page 53433]]

property such as patentable material, and personal information 
concerning individuals associated with the grant applications, the 
disclosure of which would constitute a clearly unwarranted invasion of 
personal privacy.

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel; Time-Sensitive Obesity 
Review.
    Date: July 23, 2024.
    Time: 10:00 a.m. to 11:30 a.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, NIDDK, Democracy II, Suite 
7000A, 6707 Democracy Boulevard, Bethesda, MD 20892 (Virtual 
Meeting).
    Contact Person: Michele L. Barnard, Ph.D., Scientific Review 
Officer, National Institute of Diabetes and Digestive and Kidney 
Diseases, National Institute of Health, 6707 Democracy Boulevard, 
Rm. 7353, Bethesda, MD 20892-2542, (301) 594-8898, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.847, 
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive 
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology 
and Hematology Research, National Institutes of Health, HHS)

    Dated: June 21, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-14027 Filed 6-25-24; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.